相关实验视频
Updated: Jul 5, 2025

04:53
Surgical Management of Meatal Stenosis with Meatoplasty
Published on: November 30, 2010
52.7K
库拉里诺综合征的治疗策略 复杂性与直肠狭窄症
Atsushi Harada1, Hirofumi Tomita1, Ayano Tsukizaki1
1Surgery, Tokyo Metropolitan Children's Medical Center, Tokyo, JPN.
Cureus
|January 16, 2024
概括
库拉里诺综合征 (CS) 与直肠狭窄症需要量身定制的手术方法. 了解疾病病理生理学和制定明确的治疗指南可以改善患者的治疗结果.
科学领域:
- 儿科手术 儿科手术
- 医学遗传学 医学遗传学
- 胃肠病学 胃肠病学
背景情况:
- 库拉里诺综合征 (CS) 是一种罕见的先天性疾病.
- 它的特点是前圣体质量,直肠形和圣骨骨缺陷的结合.
- 直肠狭窄症是一种影响患者管理的重大并发症.
研究的目的:
- 审查因直肠狭窄症而复杂的库拉里诺综合征 (CS) 的治疗经验和结果.
- 评估目前这种罕见疾病的治疗策略.
主要方法:
- 在1998年至2021年期间接受治疗的七名CS和直肠狭窄症患者的回顾性病例系列.
- 对前阴部质量和直肠狭窄症的外科手术进行分析.
- 直肠狭窄组织的病理检查.
主要成果:
- 预圣的群体包括瘤,脑膜瘤和脂瘤.
- 手术管理涉及病变切除,脑膜硬化术,以及各种直肠狭窄修复技术.
- 病理学揭示了无组织的光滑肌肉和狭窄组织中的原蛋白增加.
结论:
- 库拉里诺综合征 (CS) 的改善临床结果是可以实现的.
- 建立治疗流程图和了解复杂的病理生理学是至关重要的.
相关概念视频
Inflammatory Bowel Disease V: Surgical Management
147
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
147
Drugs for Treatment of Constipation-Predominant IBS
170
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
170
Drugs for Treatment of Diarrhea-Predominant IBS
176
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
176
Drugs for Treatment of Ulcerative Colitis in IBD
142
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
142
Esophageal Strictures-II: Clinical Features and Management
72
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
72
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
166
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
166

